Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacira Pharmaceuticals

22.73
-0.5800-2.49%
Volume:585.74K
Turnover:13.40M
Market Cap:1.05B
PE:-10.02
High:23.58
Open:23.31
Low:22.43
Close:23.31
Loading ...

Pacira Biosciences Inc. Announces Reorganization, Shuts Down 45-Liter Facility, Reduces Workforce by 70

Reuters
·
10 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AbbVie, McDonald's

Reuters
·
11 Jul

BRIEF-Pacira BioSciences Announces Workforce Reduction

Reuters
·
10 Jul

Pacira Pharmaceuticals Implements Workforce Reduction for Efficiency

TIPRANKS
·
10 Jul

Pacira Biosciences Inc - Announces Workforce Reduction in San Diego - SEC Filing

THOMSON REUTERS
·
10 Jul

Pacira Biosciences Inc - Estimates $2.4-$2.8 Mln Pre-Tax Charges for Termination - SEC Filing

THOMSON REUTERS
·
10 Jul

Pacira Pharmaceuticals Secures New $300M Credit Facility

TIPRANKS
·
07 Jul

Pacira Biosciences Inc - on July 3 Enters Credit Agreement With Wells Fargo - SEC Filing

THOMSON REUTERS
·
07 Jul

Pacira BioSciences Inc. Secures $300 Million Credit Agreement with Wells Fargo and Lenders, Refinances Existing Debt

Reuters
·
07 Jul

RBC Capital Sticks to Their Hold Rating for Pacira Pharmaceuticals (PCRX)

TIPRANKS
·
07 Jul

U.S. RESEARCH ROUNDUP-Analog Devices, Constellation Brands, Phibro Animal Health

Reuters
·
07 Jul

Pacira Biosciences Inc : RBC Asssumes Coverage With Sector Perform Rating; Target Price $26

THOMSON REUTERS
·
07 Jul

BRIEF-Pacira Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
04 Jul

Pacira BioSciences Announces Inducement Grants Under Amended 2014 Plan for New Employees

Reuters
·
04 Jul

Pacira debuts film spotlighting patient journey to pain relief

TIPRANKS
·
18 Jun

Pacira Pharmaceuticals Stockholders Approve Amended Incentive Plan

TIPRANKS
·
14 Jun

Pacira Biosciences Inc. Conducted Annual Stockholders Meeting

Reuters
·
14 Jun

Pacira BioSciences Announces Promising Three-Year Data on Gene Therapy PCRX-201 for Osteoarthritis of the Knee

Reuters
·
11 Jun

Pacira Biosciences Inc - Single Intra-Articular Injection of Pcrx-201 Shows Sustained Improvements in Pain, Stiffness, Function for 156 Weeks

THOMSON REUTERS
·
11 Jun

Pacira Biosciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, Pcrx-201, in Patients With Moderate-to-Severe Osteoarthritis of the Knee

THOMSON REUTERS
·
11 Jun